Physician profile
Glenn Fields
NPI 1093265837
$5,656.68
in general payments reported to CMS, 2019-2025
44 companies · $1,064 in 2025
The $1,064 reported for 2025 was more than what 88% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $486 · 2022: $1,693 · 2023: $1,083 · 2024: $1,332 · 2025: $1,064.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,426 · Education: $51.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,426.34 |
| Education | $51.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $989.46 | 2022-2025 | Xience Skypoint, Dragonfly Opstar, Xience Sierra |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $805.78 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $410.75 | 2022-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $344.59 | 2022-2025 | Jardiance |
| Pfizer INC. | $272.98 | 2021-2025 | |
| Novo Nordisk INC | $234.52 | 2021-2025 | Wegovy, Ozempic |
| Janssen Pharmaceuticals, INC | $219.81 | 2021-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $218.84 | 2021-2024 | Xifaxan, Trulance |
| Baxter Healthcare | $211.54 | 2024-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Cardiac Ambulatory Monitor |
| Janssen Biotech, INC. | $129.27 | 2022-2024 | Stelara, Simponi, Tremfya |
| Verona Pharma, INC. | $126.65 | 2025 | Ohtuvayre |
| Takeda Pharmaceuticals U.S.A., INC. | $116.01 | 2021-2025 | Entyvio, Glassia |
| Bayer Healthcare Pharmaceuticals INC. | $109.40 | 2022-2024 | |
| Inspire Medical Systems, INC. | $102.85 | 2024-2025 | Inspire |
| Amgen INC. | $96.11 | 2023-2025 | Repatha, Repatha |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $95.19 | 2021-2025 | Linq II, Tyrx |
| Abbvie INC. | $83.38 | 2022-2024 | |
| Opko Pharmaceuticals, LLC | $82.97 | 2022-2023 | Rayaldee |
| Otsuka America Pharmaceutical, INC. | $81.86 | 2022-2023 | Jynarque |
| Ironwood Pharmaceuticals, INC | $77.25 | 2022-2024 | Linzess |
| Terumo Medical Corporation | $76.85 | 2023-2025 | Metacross Otw, R2p Misago |
| Daiichi Sankyo INC. | $74.61 | 2022-2024 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $72.12 | 2024-2025 | Dupixent |
| Phathom Pharmaceuticals, INC. | $70.40 | 2024 | Voquezna |
| E.R. Squibb & Sons, L.L.C. | $61.61 | 2021-2025 | Eliquis |
| Astrazeneca Pharmaceuticals Lp | $56.44 | 2022-2024 | Farxiga, Andexxa |
| Shockwave Medical, INC | $52.96 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave C2+ Coronary |
| Boston Scientific Corporation | $44.58 | 2022-2024 | Watchman Access System |
| Merck Sharp & Dohme LLC | $43.05 | 2023 | Verquvo |
| Aimmune Therapeutics, INC. | $39.08 | 2024 | |
| Philips North America LLC | $35.53 | 2022-2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Travere Therapeutics, INC. | $22.06 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $21.89 | 2024 | |
| Abiomed | $20.57 | 2025 | |
| Aurinia Pharma U.S., INC. | $19.11 | 2021 | |
| Genzyme Corporation | $18.13 | 2024 | |
| Organon LLC | $17.29 | 2024 | |
| Kestra Medical Technology Services, INC. | $16.45 | 2024 | Assure Wcd |
| Lantheus Medical Imaging, INC. | $15.58 | 2021 | |
| Alexion Pharmaceuticals, INC. | $15.29 | 2022 | |
| Viatris Specialty LLC | $14.88 | 2025 | Yupelri |
| Mylan Specialty L.P. | $14.55 | 2023 | Yupelri |
| Nestle Healthcare Nutrition INC. | $13.14 | 2023 | |
| Sk Life Science, INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Glenn Fields listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.